FIBROGEN INC Quarterly Costs and Expenses in USD from Q3 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Fibrogen Inc quarterly/annual Costs and Expenses history and growth rate from Q3 2020 to Q4 2024.
  • Fibrogen Inc Costs and Expenses for the quarter ending December 31, 2024 was -$31.6M, a 248% decline year-over-year.
  • Fibrogen Inc Costs and Expenses for the twelve months ending December 31, 2024 was $180M, a 51.3% decline year-over-year.
  • Fibrogen Inc annual Costs and Expenses for 2024 was $180M, a 51.3% decline from 2023.
  • Fibrogen Inc annual Costs and Expenses for 2023 was $370M, a 16.4% decline from 2022.
  • Fibrogen Inc annual Costs and Expenses for 2022 was $442M, a 15.7% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $180M -$31.6M -$52.9M -248% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-17
Q3 2024 $233M $63.1M -$40.5M -39.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $273M $61.6M -$70.8M -53.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $344M $87M -$25.3M -22.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $370M $21.3M -$79.2M -78.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-17
Q3 2023 $449M $104M -$5.78M -5.28% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $455M $132M +$24.3M +22.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $430M $112M -$11.6M -9.34% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $442M $101M -$51.3M -33.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $493M $109M +$4.39M +4.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $489M $108M -$50.2M -31.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $539M $124M +$15M +13.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $524M $152M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $105M +$93.3M +797% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $158M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $109M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $11.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.